Influence of tumour micro-environment heterogeneity on therapeutic response

MR Junttila, FJ De Sauvage - Nature, 2013 - nature.com
Tumour formation involves the co-evolution of neoplastic cells together with extracellular
matrix, tumour vasculature and immune cells. Successful outgrowth of tumours and eventual …

The role of microglia and macrophages in glioma maintenance and progression

D Hambardzumyan, DH Gutmann… - Nature neuroscience, 2016 - nature.com
There is a growing recognition that gliomas are complex tumors composed of neoplastic and
non-neoplastic cells, which each individually contribute to cancer formation, progression …

Neurofibromatosis type 1

DH Gutmann, RE Ferner, RH Listernick… - Nature Reviews …, 2017 - nature.com
Neurofibromatosis type 1 is a complex autosomal dominant disorder caused by germline
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …

[HTML][HTML] Principles of cancer therapy: oncogene and non-oncogene addiction

J Luo, NL Solimini, SJ Elledge - Cell, 2009 - cell.com
Cancer is a complex collection of distinct genetic diseases united by common hallmarks.
Here, we expand upon the classic hallmarks to include the stress phenotypes of …

[HTML][HTML] Activity of selumetinib in neurofibromatosis type 1–related plexiform neurofibromas

E Dombi, A Baldwin, LJ Marcus… - … England Journal of …, 2016 - Mass Medical Soc
Background Effective medical therapies are lacking for the treatment of neurofibromatosis
type 1–related plexiform neurofibromas, which are characterized by elevated RAS–mitogen …

Tumors as organs: complex tissues that interface with the entire organism

M Egeblad, ES Nakasone, Z Werb - Developmental cell, 2010 - cell.com
Solid tumors are not simply clones of cancer cells. Instead, they are abnormal organs
composed of multiple cell types and extracellular matrix. Some aspects of tumor …

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

MHGP Raaijmakers, S Mukherjee, S Guo, S Zhang… - Nature, 2010 - nature.com
Mesenchymal cells contribute to the 'stroma'of most normal and malignant tissues, with
specific mesenchymal cells participating in the regulatory niches of stem cells. By examining …

Neurofibromatosis type 1: a multidisciplinary approach to care

AC Hirbe, DH Gutmann - The Lancet Neurology, 2014 - thelancet.com
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high
predisposition to develop both benign and malignant tumours. Although many …

A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

N Ratner, SJ Miller - Nature Reviews Cancer, 2015 - nature.com
Abstract Neurofibromatosis type 1 (NF1) is a common genetic disorder that predisposes
affected individuals to tumours. The NF1 gene encodes a RAS GTPase-activating protein …

Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1

C Anastasaki, J Mo, JK Chen, J Chatterjee… - Nature …, 2022 - nature.com
Neuronal activity is emerging as a driver of central and peripheral nervous system cancers.
Here, we examined neuronal physiology in mouse models of the tumor predisposition …